Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 04/19/22 | PRE 14A | Form PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition | 25 | |
| 04/15/22 | 3/A | Form 3/A: Initial statement of beneficial ownership of securities | 1 | |
| 03/21/22 | 10-K | Form 10-K: Annual report pursuant to Section 13 and 15(d) |
|
85 |
| 03/21/22 | 8-K | Form 8-K: Current report filing |
|
5 |
| 03/15/22 | 8-K | Form 8-K: Current report filing |
|
14 |
| 02/25/22 | 8-K | Form 8-K: Current report filing |
|
9 |
| 02/24/22 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 02/24/22 | 3 | Form 3: Initial statement of beneficial ownership of securities | 2 | |
| 02/15/22 | SC 13G/A | Form SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | 3 | |
| 02/14/22 | SC 13G/A | Form SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | 8 |